BackDOD Biotech Public , Ltd. Overview

DOD Biotech Public , Ltd. Current Cash

Track DOD Biotech Public , Ltd.'s current cash ($59M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$59.47M
↓ 70.17% YoYΔ $-139.92M vs prior year quarter

Peer trimmed avg / median

Loading

DOD Biotech Public , Ltd. Current Cash History

Loading

DOD Biotech Public , Ltd. vs. peers: Current Cash Comparison

Loading

DOD Biotech Public , Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DOD Biotech Public , Ltd. (DOD.BK) FAQ

The latest current cash for DOD.BK is $59M as of June 2026. That compares with $200M in the prior-year period — down 70.2% year over year. Investors often review this figure alongside DOD Biotech Public , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DOD.BK's current cash moved from $200M to $59M — a 70.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DOD Biotech Public , Ltd.'s operating scale or balance-sheet position.

A current cash figure of $59M for DOD.BK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DOD.BK's current cash ($59M), review year-over-year change from $200M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.